4FRONT VENTURES CORP - FFNTF STOCK NEWS

4Front Ventures Corp. reported significant financial growth for FY 2021, with GAAP revenue rising 81% year-over-year to $104.6 million and Adjusted EBITDA surging 479% to $34.0 million. The company's Systemwide Pro Forma Revenue increased 50% to $132.7 million. Operational advancements include a new production facility in California, expected to drive future growth, and successful acquisitions like New England Cannabis Corporation. As of December 31, 2021, the company held $22.6 million in cash and strategic plans for expansion in key markets.

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) will report its financial results for Q4 and full year 2021 on March 30, 2022, after market close. The company will host a conference call at 5:00 p.m. ET to discuss the results and current business trends. 4Front operates in key cannabis markets across California, Illinois, Massachusetts, Michigan, and Washington, and has established a strong reputation for its cultivation and production methodologies.

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) has acquired New England Cannabis Corporation (NECC), enhancing its operational footprint in Massachusetts. This acquisition includes a fully operational, 55,000 sq. ft. cultivation facility that will more than double the Company’s flower canopy to over 30,000 sq. ft. The Massachusetts Cannabis Control Commission approved the acquisition on January 20, 2022. The deal is expected to be immediately accretive to the Company’s 2022 EBITDA and allows for significant market penetration in a competitive limited-license state.

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) announced participation in Needham's 24th Annual Virtual Growth Conference from January 10-14, 2022. Andrew Thut, Chief Investment Officer and Interim Chief Financial Officer, will speak on January 14 at 12:30 PM ET. The company plans to conduct small group and one-on-one meetings with investors throughout the event. 4Front is a multi-state cannabis operator with a reputation for low-cost cultivation and production, managing operations in key markets including California, Illinois, Michigan, and Washington.

4Front Ventures Corp. (CSE: FFNT) reported its Q3 2021 financial results, showcasing a 48% year-over-year increase in systemwide pro forma revenue to $33.1 million. GAAP revenue rose 70% to $25.9 million, but both metrics declined 4% sequentially. Adjusted EBITDA soared 103% to $7.5 million, maintaining a margin of 23%. The company initiated construction of a 558,000 sq. ft. facility in Illinois and opened its 170,000 sq. ft. manufacturing site in California. A proposed acquisition of New England Cannabis Corporation aims to enhance its Massachusetts presence, targeting significant long-term revenue opportunities.

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) will release its third-quarter financial results for the period ending September 30, 2021, on November 17, 2021, after market close. Following the report, a conference call is scheduled at 5:00 p.m. Eastern Time to discuss the outcomes and current business trends. 4Front Ventures operates in key cannabis markets, including California and Massachusetts, and boasts a portfolio of over 20 cannabis brands and 1800 products. The company aims to enhance shareholder value with its extensive industry expertise.

4Front Ventures Corp has received its business license for a new 170,000 sq. ft. cannabis manufacturing facility in Commerce, California. This facility, among the largest globally, will produce nine of 4Front's brands and 164 different SKUs, utilizing advanced automation and technologies. It aims to produce significantly more than its other facilities, with a distribution partnership with Nabis. This operational milestone aligns with 4Front's recent agreement to acquire New England Cannabis Corporation, strengthening its market presence in California and Massachusetts.

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) announced its agreement to acquire New England Cannabis Corporation (NECC) for a total consideration of US$55 million. This acquisition is expected to significantly boost 4Front's EBITDA for 2022 and enhance its market share in the growing Massachusetts cannabis market. The deal will more than double 4Front's total flower canopy and expand processing capabilities. The cash portion of the deal is financed through a US$15 million convertible note offering. The closing of the transaction is subject to regulatory approval.